Drug profile · INN
parathyroid hormone
NATPAR
parathyroid hormone (NATPAR) is a parathyroid hormone receptor agonist. Associated with Takeda. Route of administration: injection. Current US regulatory status: approved.
Drug details — parathyroid hormone
- US status
- approved
- Class
- Systemic hormonal preparations (H05)
- Route
- INJECTION
- Patents
- 4
- Programs
- 5
- Data quality
- 0.89
Quick answer
parathyroid hormone (NATPAR) is a parathyroid hormone receptor agonist. Associated with Takeda. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Parathyroid hormone receptor agonist
Primary target: Parathyroid hormone/parathyroid hormone-related peptide receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is parathyroid hormone?
parathyroid hormone (NATPAR) is a parathyroid hormone receptor agonist. Associated with Takeda. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for parathyroid hormone?
NATPAR is a marketed brand name for parathyroid hormone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of parathyroid hormone?
parathyroid hormone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.